ArticleHematological oncology2026

Clinical Impact of BTK Inhibitor Exposure in LymphGen-Defined MCD Diffuse Large B-Cell Lymphoma.

Shiyu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.